Novel Treatment Strategy for NRAS-Mutated Melanoma through a Selective Inhibitor of CD147/VEGFR-2 Interaction

Researchers showed that CD147i, a specific inhibitor of CD147/VEGFR-2 interaction represented a potential therapeutic strategy for NRASmut melanoma cells.